Expression of a CD20 specific chimeric antigen receptor enhances cytotoxic activity of NK cells and overcomes NK-resistance of leukemia and lymphoma cells. - Mueller,T.; Uherek,C.; Maki,G.; Chow,KU.; Klingemann,HG.; Tonn,T.; Wels,WS. (Canc Immunol Immunother)